New York Network Ipa INC

New York Network Ipa INC was paid $529.97M by Medicaid between Jan 2018 and Dec 2024, across 786 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 19% of everything it billed.

Compared with peers

Next to other Exclusive Provider Organization providers in New York

Rank by total paid#1 of 24

Median peer was paid$123K

This provider vs. median4,318×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	338,312	$16.62M
2019	549,516	$25.70M
2020	697,445	$36.03M
2021	1,447,741	$76.57M
2022	3,772,729	$174.81M
2023	3,274,737	$145.78M
2024incomplete	1,081,924	$54.46M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	19%	1,406,305	412,026	$99.14M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	8.7%	552,614	485,889	$46.05M
97530	Therapeutic activities, direct patient contact, each 15 minutes	6.7%	531,363	159,366	$35.37M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	6.6%	1,427,961	397,225	$34.73M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	6.2%	1,403,917	411,667	$33.01M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	3.8%	670,554	193,646	$20.37M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	3.5%	161,940	145,677	$18.79M
77067	Screening mammography, bilateral, including computer-aided detection	3.0%	122,330	122,243	$15.81M
90837	Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient	2.8%	113,778	34,682	$14.94M
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	2.6%	481,751	139,801	$13.55M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	2.5%	179,456	44,836	$13.06M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	2.4%	218,150	124,965	$12.74M

774 more codes

97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	2.3%	574,708	$12.14M
76700	Ultrasound, abdominal, real time with image documentation; complete	1.7%	86,598	$9.14M
76641		1.6%	78,392	$8.47M
99203	Doctor's office visit, new patient (routine)	1.6%	81,384	$8.24M
90834	Psychotherapy session, about 45 minutes	1.1%	65,131	$5.72M
77063	Screening digital breast tomosynthesis, bilateral	<1%	101,726	$5.15M
76830	Ultrasound, transvaginal	<1%	34,755	$3.99M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	119,606	$3.78M
76536		<1%	33,737	$3.60M
99204	Doctor's office visit, new patient (more involved)	<1%	23,501	$3.47M
93975		<1%	17,193	$3.36M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	29,426	$2.57M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	14,783	$2.51M
97533		<1%	43,001	$2.34M
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	54,417	$2.26M
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	28,913	$2.13M
93880		<1%	13,173	$2.13M
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	16,813	$2.02M
71046	Radiologic examination, chest; 2 views	<1%	64,369	$1.99M
90791	Psychiatric diagnostic evaluation	<1%	13,332	$1.90M
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	212,362	$1.77M
76825		<1%	6,074	$1.66M
77065	Tomosynthesis, mammo	<1%	12,202	$1.55M
70551	Magnetic resonance imaging, brain; without contrast material	<1%	7,642	$1.53M
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	7,763	$1.52M
93970		<1%	8,645	$1.46M
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	7,015	$1.40M
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	22,713	$1.33M
19083		<1%	2,353	$1.28M
97161		<1%	20,837	$1.28M
77066	Tomosynthesis, mammo	<1%	7,838	$1.27M
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	36,975	$1.26M
97162		<1%	20,114	$1.26M
90853	Group psychotherapy (other than of a multiple-family group)	<1%	47,843	$1.23M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	3,726	$1.16M
72197		<1%	3,315	$1.12M
95923		<1%	10,757	$1.11M
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	7,235	$1.04M
90785		<1%	75,273	$1.04M
97535	Self-care/home management training, each 15 minutes	<1%	41,712	$1.01M
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	31,519	$997K
93925		<1%	4,513	$956K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	4,126	$923K
76642		<1%	11,020	$910K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	5,042	$889K
93886		<1%	4,467	$850K
95886		<1%	6,951	$804K
73562		<1%	19,870	$802K
76770		<1%	10,079	$799K
92526		<1%	23,783	$750K
93979		<1%	6,626	$747K
93890		<1%	3,866	$740K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	6,414	$719K
74178		<1%	2,045	$717K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	6,361	$700K
73630		<1%	20,369	$698K
97032		<1%	62,721	$677K
93976		<1%	8,256	$671K
72100		<1%	16,733	$649K
74183		<1%	1,857	$636K
93922		<1%	8,076	$634K
73221		<1%	3,133	$617K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	2,734	$610K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	4,644	$601K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	5,548	$593K
36466		<1%	467	$581K
78815	Positron emission tomography (PET) for limited area imaging	<1%	384	$580K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	9,773	$580K
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	5,450	$564K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,717	$563K
72141		<1%	3,173	$553K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	6,000	$539K
97124		<1%	22,640	$536K
95921		<1%	7,024	$516K
93892		<1%	3,124	$516K
L3001	Foot, insert, removable, molded to patient model, spenco, each	<1%	4,594	$515K
95912		<1%	3,056	$510K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,927	$503K
97165		<1%	5,358	$498K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	33,690	$497K
67210		<1%	1,179	$496K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	6,196	$495K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	141,892	$493K
31231		<1%	2,822	$485K
19081		<1%	898	$475K
99443		<1%	4,319	$473K
71250		<1%	3,715	$471K
77080		<1%	15,856	$461K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	3,912	$456K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	6,003	$442K
77062		<1%	7,050	$441K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	4,094	$435K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	749	$425K
93923		<1%	3,706	$424K
92523		<1%	2,807	$406K
99401		<1%	23,285	$395K
73030		<1%	11,008	$375K
70486		<1%	2,793	$368K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	19,042	$357K
92250		<1%	9,928	$353K
99051		<1%	75,268	$347K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	4,133	$332K
97035		<1%	33,152	$326K
77061		<1%	6,993	$325K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	3,482	$312K
99442		<1%	4,169	$308K
97164		<1%	8,181	$303K
95913		<1%	1,432	$290K
93000		<1%	19,735	$268K
73610		<1%	7,372	$266K
97116		<1%	14,477	$266K
73130		<1%	7,315	$264K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	12,251	$254K
90832	Psychotherapy session, about 30 minutes	<1%	3,678	$253K
76775		<1%	5,700	$253K
99490	Ccm add 20min	<1%	7,770	$248K
72050		<1%	4,624	$245K
11730		<1%	3,007	$240K
73718		<1%	1,072	$237K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	7,516	$231K
90836		<1%	3,005	$224K
93971		<1%	2,007	$223K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	1,740	$221K
95911		<1%	1,380	$216K
83970		<1%	5,086	$216K
29200		<1%	8,827	$212K
72110		<1%	4,277	$211K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	18,678	$211K
93978		<1%	1,425	$210K
73110		<1%	5,194	$209K
70450	Computed tomography, head or brain; without contrast material	<1%	2,735	$208K
17110		<1%	1,916	$200K
98928		<1%	3,573	$198K
94010		<1%	7,926	$194K
76870		<1%	1,991	$192K
58340		<1%	805	$191K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	1,631	$190K
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	4,618	$180K
77049		<1%	516	$176K
92134		<1%	5,147	$174K
92540		<1%	2,239	$172K
71271		<1%	1,327	$168K
92546		<1%	2,221	$159K
36478		<1%	147	$158K
93325		<1%	6,116	$152K
92587		<1%	4,166	$149K
72040		<1%	4,079	$147K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	1,405	$147K
95924		<1%	1,271	$147K
99215	Doctor's office visit, returning patient (complex)	<1%	972	$144K
92060		<1%	2,306	$141K
93931		<1%	1,502	$141K
95910		<1%	1,185	$141K
76819	Fetal biophysical profile; without non-stress testing	<1%	1,818	$139K
10061		<1%	875	$137K
L3219	Orthopedic footwear, mens shoe, oxford, each	<1%	1,535	$135K
20611		<1%	1,454	$135K
29515		<1%	1,821	$134K
L3215	Orthopedic footwear, ladies shoe, oxford, each	<1%	1,638	$129K
72082		<1%	1,884	$128K
72070		<1%	4,089	$124K
75574		<1%	511	$124K
L3060	Foot, arch support, removable, premolded, longitudinal/ metatarsal, each	<1%	2,297	$123K
99050		<1%	23,125	$123K
73502		<1%	2,638	$123K
99308	Subsequent nursing facility care, per day, straightforward	<1%	2,201	$122K
10040		<1%	1,061	$122K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	413	$122K
29520		<1%	5,025	$122K
90838		<1%	1,088	$117K
76801		<1%	1,034	$115K
95117		<1%	9,503	$112K
95816		<1%	381	$111K
88312		<1%	2,280	$110K
82308		<1%	4,031	$110K
29125		<1%	1,585	$109K
82670		<1%	3,421	$101K
84146		<1%	5,008	$101K
12001		<1%	1,010	$99K
92235		<1%	891	$99K
93888		<1%	1,004	$98K
67028	Intravitreal injection of a pharmacologic agent	<1%	966	$97K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,452	$93K
64615		<1%	635	$93K
92552		<1%	5,178	$92K
36475		<1%	108	$92K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	217	$89K
29530		<1%	4,185	$88K
77072		<1%	3,364	$88K
72195		<1%	390	$87K
88313		<1%	2,993	$87K
72146		<1%	527	$86K
73140		<1%	2,379	$85K
84403		<1%	3,079	$85K
84681		<1%	4,078	$83K
99232	Hospital visit by a doctor, follow-up day	<1%	1,388	$82K
70544		<1%	694	$81K
84439		<1%	9,190	$80K
84443	Thyroid stimulating hormone (TSH)	<1%	9,284	$80K
20610		<1%	1,250	$80K
73560		<1%	2,270	$78K
73522		<1%	1,417	$75K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	9,382	$74K
92002		<1%	939	$74K
90792	Psychiatric diagnostic evaluation with medical services	<1%	505	$74K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	3,394	$72K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	3,392	$72K
83001		<1%	3,694	$71K
74018		<1%	2,386	$71K
73080		<1%	2,120	$70K
76882		<1%	1,574	$70K
29240		<1%	3,137	$70K
77085		<1%	1,355	$69K
L3202	Orthopedic shoe, oxford with supinator or pronator, child	<1%	1,941	$68K
83036	Hemoglobin; glycosylated (A1C)	<1%	7,032	$68K
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	9,060	$67K
86376		<1%	4,768	$67K
83002		<1%	3,508	$67K
69210		<1%	1,211	$65K
L3010	Foot, insert, removable, molded to patient model, longitudinal arch support, each	<1%	570	$65K
A5500	For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe	<1%	514	$64K
99385		<1%	541	$63K
99284	Emergency room visit (serious)	<1%	835	$63K
10060		<1%	533	$63K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	1,227	$63K
86800		<1%	4,761	$62K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	560	$61K
84144		<1%	2,874	$60K
92567		<1%	4,376	$60K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	4,596	$59K
95938		<1%	394	$59K
10005		<1%	449	$59K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	4,080	$59K
93229		<1%	161	$58K
87070		<1%	7,422	$58K
92537		<1%	2,187	$58K
11721		<1%	2,351	$56K
82024		<1%	1,362	$56K
G0444	Annual depression screening, 5 to 15 minutes	<1%	4,913	$54K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	10,329	$53K
76377		<1%	1,324	$52K
J1756	Injection, iron sucrose, 1 mg	<1%	2,414	$52K
92083		<1%	871	$51K
88342		<1%	1,412	$51K
82607		<1%	4,069	$51K
92522		<1%	683	$50K
83525		<1%	4,199	$50K
31575		<1%	433	$49K
92588		<1%	906	$48K
74740		<1%	547	$47K
92524		<1%	631	$46K
94060		<1%	1,028	$46K
11056		<1%	1,160	$45K
99222	Initial hospital care, per day, moderate complexity	<1%	381	$45K
97113		<1%	660	$44K
73218		<1%	168	$44K
73590		<1%	1,362	$44K
80053	Comprehensive metabolic panel	<1%	4,408	$43K
76000		<1%	1,007	$43K
82626		<1%	1,810	$43K
81002		<1%	21,720	$43K
L3332	Lift, elevation, inside shoe, tapered, up to one-half inch	<1%	898	$42K
94729		<1%	1,114	$42K
82728		<1%	3,058	$42K
92286		<1%	1,164	$41K
84481		<1%	4,637	$41K
99350	Prolong home eval add 15m	<1%	239	$40K
A9581	Injection, gadoxetate disodium, 1 ml	<1%	341	$39K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	118	$39K
92025		<1%	1,269	$39K
99497		<1%	797	$39K
82746		<1%	3,067	$38K
76881		<1%	931	$37K
70491		<1%	194	$37K
97166		<1%	389	$36K
92133		<1%	1,087	$35K
72220		<1%	1,130	$35K
88112		<1%	1,975	$35K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	2,375	$35K
99205	Prolong outpt/office vis	<1%	158	$34K
92610		<1%	521	$34K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	271	$34K
84442		<1%	3,951	$34K
19084		<1%	84	$34K
L3000	Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each	<1%	156	$34K
A5512	For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each	<1%	514	$33K
76827		<1%	469	$33K
95943		<1%	400	$33K
11732		<1%	1,296	$32K
82533		<1%	1,905	$32K
94727		<1%	1,111	$31K
93015		<1%	512	$31K
70480		<1%	194	$31K
92557		<1%	967	$31K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	3,751	$30K
99439		<1%	657	$30K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,063	$29K
71045	Radiologic examination, chest; single view	<1%	2,399	$29K
92551		<1%	4,557	$27K
80061	Lipid panel	<1%	4,406	$26K
87184		<1%	4,204	$26K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	92	$26K
93702		<1%	258	$26K
11421		<1%	260	$25K
99441		<1%	607	$25K
84480		<1%	4,421	$25K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	198	$25K
92081		<1%	802	$25K
12011		<1%	198	$24K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	203	$24K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	7,682	$24K
73564		<1%	532	$24K
76820		<1%	520	$23K
76818		<1%	207	$23K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	104	$23K
73700		<1%	176	$22K
68761		<1%	138	$22K
87428		<1%	690	$22K
83735		<1%	4,358	$22K
11901		<1%	358	$22K
90686		<1%	6,235	$21K
76885		<1%	193	$21K
L4396	Static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	161	$21K
82977		<1%	4,215	$21K
90849		<1%	620	$21K
84100		<1%	4,347	$21K
70543		<1%	62	$21K
73090		<1%	700	$21K
96367		<1%	309	$20K
86769		<1%	599	$20K
99386		<1%	148	$20K
11755		<1%	206	$19K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	1,100	$19K
76857		<1%	503	$19K
10120		<1%	111	$19K
92579		<1%	681	$18K
81000		<1%	4,955	$18K
97163		<1%	295	$18K
29131		<1%	301	$18K
99349		<1%	150	$18K
99406		<1%	1,557	$18K
72114		<1%	270	$17K
83615		<1%	3,312	$17K
72052		<1%	264	$16K
82550		<1%	3,253	$16K
84550		<1%	3,499	$16K
73552		<1%	433	$16K
92653		<1%	280	$16K
92555		<1%	1,112	$16K
71100		<1%	415	$15K
82627		<1%	687	$15K
92201		<1%	715	$15K
83540		<1%	3,021	$15K
92550		<1%	1,051	$15K
99305		<1%	215	$15K
93268		<1%	95	$15K
94618		<1%	604	$15K
11720		<1%	688	$15K
G0447	Face-to-face behavioral counseling for obesity, 15 minutes	<1%	1,927	$15K
71275	Computed tomographic angiography, chest, with contrast material	<1%	139	$14K
90674		<1%	638	$14K
90756		<1%	482	$14K
90960	End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits	<1%	78	$14K
T1013	Sign language or oral interpretive services, per 15 minutes	<1%	1,246	$14K
93351		<1%	76	$14K
J3415	Injection, pyridoxine hcl, 100 mg	<1%	1,286	$14K
29540		<1%	1,388	$14K
80305		<1%	1,958	$13K
76514		<1%	1,311	$13K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	72	$13K
72170		<1%	441	$13K
99402		<1%	2,343	$12K
95930		<1%	148	$12K
11900		<1%	264	$12K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	4,276	$12K
20553		<1%	195	$12K
93224		<1%	152	$12K
27096		<1%	66	$11K
88120		<1%	64	$11K
76821		<1%	130	$11K
83550		<1%	2,166	$11K
57150		<1%	224	$11K
M0244	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency	<1%	14	$11K
70220		<1%	274	$11K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	568	$10K
73060		<1%	319	$10K
97026		<1%	2,095	$10K
87340		<1%	958	$10K
93298		<1%	532	$10K
L2820	Addition to lower extremity orthosis, soft interface for molded plastic, below knee section	<1%	148	$10K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	6,327	$10K
76813		<1%	78	$10K
86708		<1%	960	$10K
86803		<1%	963	$10K
00731		<1%	85	$10K
99243		<1%	93	$9K
99239	Hospital discharge day management, more than 30 minutes	<1%	87	$9K
98927		<1%	156	$9K
74181		<1%	51	$9K
G0268	Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing	<1%	190	$9K
92521		<1%	90	$9K
90694		<1%	205	$9K
74019		<1%	230	$9K
99309	Subsequent nursing facility care, per day, low to moderate complexity	<1%	202	$9K
L1971	Ankle foot orthosis, plastic or other material with ankle joint, with or without dorsiflexion assist, prefabricated, includes fitting and adjustment	<1%	53	$9K
95812		<1%	27	$8K
92145		<1%	648	$8K
98925		<1%	264	$8K
93350		<1%	52	$8K
87110		<1%	994	$8K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	1,446	$8K
11102		<1%	78	$7K
72084		<1%	74	$7K
92020		<1%	301	$7K
64483		<1%	30	$7K
99307		<1%	329	$7K
86706		<1%	960	$7K
86704		<1%	958	$7K
95044		<1%	30	$7K
86328		<1%	249	$7K
92548		<1%	537	$7K
95700		<1%	26	$7K
99457		<1%	874	$7K
73620		<1%	243	$6K
93272		<1%	199	$6K
99238	Hospital discharge day management, 30 minutes or less	<1%	114	$6K
72131		<1%	54	$6K
84305		<1%	296	$6K
81025		<1%	3,165	$6K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	590	$6K
88174		<1%	303	$6K
99283	Emergency room visit (moderate)	<1%	121	$6K
96127		<1%	1,079	$5K
J9035	Injection, bevacizumab, 10 mg	<1%	68	$5K
86580		<1%	1,074	$5K
76981		<1%	374	$5K
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	408	$5K
51741		<1%	436	$5K
0072A		<1%	114	$5K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	1,219	$5K
L3485	Heel, pad, removable for spur	<1%	144	$5K
92508	Group treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	209	$5K
95819		<1%	13	$5K
95708		<1%	72	$5K
99201		<1%	94	$5K
0071A		<1%	105	$5K
J2785	Injection, regadenoson, 0.1 mg	<1%	24	$5K
11100		<1%	78	$5K
92225		<1%	160	$4K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	3,511	$4K
90688		<1%	252	$4K
99407		<1%	309	$4K
83003		<1%	254	$4K
17000		<1%	192	$4K
51798		<1%	456	$4K
0012A		<1%	99	$4K
L3100	Hallus-valgus night dynamic splint, prefabricated, off-the-shelf	<1%	106	$4K
84702		<1%	324	$4K
86762		<1%	256	$4K
93356		<1%	292	$4K
36415	Collection of venous blood by venipuncture	<1%	61,515	$4K
97168		<1%	64	$4K
71101		<1%	90	$4K
81003		<1%	2,020	$4K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	370	$4K
92226		<1%	134	$4K
80414		<1%	70	$4K
86765		<1%	244	$3K
84270		<1%	539	$3K
72158		<1%	12	$3K
92202		<1%	316	$3K
92586		<1%	648	$3K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	33	$3K
74170		<1%	13	$3K
0011A		<1%	79	$3K
62323		<1%	14	$3K
77081		<1%	852	$3K
97760		<1%	97	$3K
78306		<1%	12	$3K
0031A		<1%	103	$3K
97039		<1%	421	$3K
64484		<1%	30	$3K
98926		<1%	76	$3K
31237		<1%	18	$3K
87081		<1%	561	$3K
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	715	$3K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	420	$3K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	69	$3K
95027		<1%	109	$3K
72202		<1%	68	$3K
99454		<1%	361	$3K
99285	Emergency room visit (most serious)	<1%	24	$3K
95723		<1%	12	$3K
G0438	Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit	<1%	14	$3K
73660		<1%	94	$3K
J3411	Injection, thiamine hcl, 100 mg	<1%	1,131	$3K
87807		<1%	219	$2K
93320		<1%	39	$2K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	12	$2K
92570		<1%	88	$2K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	1,307	$2K
94621		<1%	15	$2K
86141		<1%	234	$2K
90656		<1%	1,269	$2K
87210		<1%	639	$2K
82784		<1%	72	$2K
A9585	Injection, gadobutrol, 0.1 ml	<1%	96	$2K
90658		<1%	640	$2K
99188		<1%	161	$2K
57454		<1%	12	$2K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	41	$2K
72125	Computed tomography, cervical spine; without contrast material	<1%	48	$2K
73200		<1%	14	$2K
93882		<1%	19	$2K
86735		<1%	244	$2K
86787		<1%	244	$2K
88341		<1%	36	$2K
72275		<1%	28	$2K
86592		<1%	584	$2K
86003		<1%	15	$2K
0399T		<1%	44	$2K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	249	$2K
93040		<1%	215	$2K
76942		<1%	41	$2K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	11,097	$2K
93228		<1%	161	$2K
29580		<1%	42	$2K
99383		<1%	12	$2K
A9576	Injection, gadoteridol, (prohance multipack), per ml	<1%	80	$2K
90715		<1%	349	$2K
L3260	Surgical boot/shoe, each	<1%	68	$2K
97010		<1%	31,107	$2K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	37	$1K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	69	$1K
99381		<1%	12	$1K
82565		<1%	329	$1K
87631		<1%	35	$1K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,555	$1K
82950		<1%	231	$1K
60300		<1%	12	$1K
J7050	Infusion, normal saline solution, 250 cc	<1%	2,033	$1K
70360		<1%	36	$1K
L3216	Orthopedic footwear, ladies shoe, depth inlay, each	<1%	13	$1K
99342		<1%	14	$1K
72081		<1%	26	$1K
86677		<1%	466	$1K
0004A		<1%	23	$1K
92585		<1%	12	$978.12
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	154	$956.92
29550		<1%	78	$956.30
36406		<1%	70	$886.56
92652		<1%	12	$883.92
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	214	$864.84
99304		<1%	13	$854.75
92553		<1%	41	$814.20
95012		<1%	94	$789.94
87077		<1%	77	$737.20
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	363	$731.85
84153		<1%	40	$710.09
86160		<1%	72	$693.66
70547		<1%	17	$675.09
G0008	Administration of influenza virus vaccine	<1%	161	$661.14
0013A		<1%	26	$650.00
J0613	Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg	<1%	374	$629.89
94375		<1%	90	$624.04
E0116	Crutch, underarm, other than wood, adjustable or fixed, with pad, tip, handgrip, with or without shock absorber, each	<1%	51	$584.50
92511		<1%	13	$582.42
0134A		<1%	17	$581.25
L3908	Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf	<1%	13	$570.00
90655		<1%	42	$568.48
71110		<1%	12	$564.58
0064A		<1%	12	$541.32
99422		<1%	30	$529.92
11420		<1%	26	$492.80
0003A		<1%	16	$480.00
73600		<1%	14	$427.64
0124A		<1%	12	$426.25
94762		<1%	245	$423.36
97014		<1%	8,531	$412.78
G2012	Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	<1%	29	$404.57
90472	Immunization administration, each additional vaccine (list separately)	<1%	25	$375.00
G0446	Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes	<1%	94	$366.17
87625		<1%	13	$365.69
85651		<1%	182	$363.78
92015	Determination of refractive state	<1%	13,142	$363.14
84703		<1%	168	$338.80
88323		<1%	14	$330.56
69209		<1%	19	$328.38
94726		<1%	39	$321.23
90710		<1%	135	$299.42
81005		<1%	167	$298.74
96381		<1%	13	$292.76
83690		<1%	49	$283.97
90461		<1%	3,904	$274.14
99459		<1%	13	$270.48
94664		<1%	157	$263.32
83655		<1%	171	$259.24
76376		<1%	236	$257.51
87486		<1%	12	$257.16
87581		<1%	12	$257.16
97810		<1%	154	$254.08
84154		<1%	12	$249.81
11305		<1%	14	$245.28
96361	Intravenous infusion, hydration; each additional hour	<1%	16	$243.84
0001A		<1%	31	$240.00
Q2035	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)	<1%	14	$230.40
96130		<1%	138	$225.04
94200		<1%	220	$219.48
94760		<1%	11,661	$212.00
82310		<1%	44	$203.20
90707		<1%	397	$200.00
86403		<1%	52	$195.00
11719		<1%	13	$194.04
82150		<1%	37	$187.36
92285		<1%	191	$182.17
84295		<1%	37	$177.97
96101		<1%	120	$167.52
G0442	Annual alcohol misuse screening, 5 to 15 minutes	<1%	69	$167.33
86703		<1%	14	$163.10
J1020	Injection, methylprednisolone acetate, 20 mg	<1%	35	$162.96
90901		<1%	688	$161.72
90716		<1%	856	$160.00
36000		<1%	951	$151.64
86140		<1%	36	$147.60
85018		<1%	87	$138.58
84132		<1%	37	$138.04
84520		<1%	41	$132.48
83861		<1%	346	$125.45
90744		<1%	1,050	$122.88
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	188	$107.87
G0445	High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes	<1%	40	$102.58
99173		<1%	13,264	$94.29
90672		<1%	198	$86.79
82962		<1%	1,523	$78.80
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	235	$73.42
97802		<1%	6,444	$70.10
36410		<1%	1,444	$64.38
J2704	Injection, propofol, 10 mg	<1%	99	$58.54
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	104	$52.69
82270		<1%	14	$47.60
90633		<1%	981	$44.16
96161		<1%	14	$40.88
29130		<1%	27	$35.99
97803		<1%	1,090	$34.35
95831		<1%	30	$33.20
92547		<1%	746	$32.81
P3001	Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician	<1%	16	$32.39
96160		<1%	13	$31.50
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	43	$28.86
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	15	$28.53
84436		<1%	887	$28.50
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	13	$13.47
G0506	Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service)	<1%	97	$10.79
J7610	Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg	<1%	67	$9.56
99174		<1%	625	$7.27
99177		<1%	142	$5.81
82247		<1%	186	$5.02
94761		<1%	54	$5.00
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	<1%	59	$2.95
H0033	Oral medication administration, direct observation	<1%	56	$1.12
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	<1%	16,838	$0.92
99001		<1%	441	$0.58
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	<1%	19	$0.17
H0001	Alcohol and/or drug assessment	<1%	1,976	$0.16
99000		<1%	40,168	$0.12
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	174	$0.03
H0049	Alcohol and/or drug screening	<1%	232	$0.01
90651		<1%	73	$0.01
99072		0%	22,448	$0.00
90713		0%	1,798	$0.00
G8752	Most recent systolic blood pressure < 140 mmhg	0%	1,184	$0.00
90670		0%	2,338	$0.00
99080		0%	844	$0.00
G8417	Bmi is documented above normal parameters and a follow-up plan is documented	0%	5,134	$0.00
90700		0%	2,320	$0.00
98960		0%	4,243	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	573	$0.00
90648		0%	723	$0.00
A4550	Surgical trays	0%	726	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	573	$0.00
90734		0%	422	$0.00
G9622	Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method	0%	1,036	$0.00
99354		0%	60	$0.00
G9820	Documentation of a chlamydia screening test with proper follow-up	0%	2,256	$0.00
G8476	Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg	0%	40	$0.00
A4595	Electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes)	0%	532	$0.00
G8783	Normal blood pressure reading documented, follow-up not required	0%	1,069	$0.00
92582		0%	525	$0.00
90671		0%	450	$0.00
S9470	Nutritional counseling, dietitian visit	0%	629	$0.00
G9316	Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family	0%	99	$0.00
G9551	Final reports for imaging studies without an incidentally found lesion noted	0%	454	$0.00
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	0%	207	$0.00
G9744	Patient not eligible due to active diagnosis of hypertension	0%	224	$0.00
92504		0%	89	$0.00
97799		0%	457	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	199	$0.00
97012		0%	115	$0.00
4040F		0%	27	$0.00
G8598	Aspirin or another antiplatelet therapy used	0%	86	$0.00
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	0%	131	$0.00
91300		0%	43	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	197	$0.00
82042		0%	14	$0.00
83721		0%	229	$0.00
G8482	Influenza immunization administered or previously received	0%	200	$0.00
99408		0%	204	$0.00
90687		0%	16	$0.00
3078F		0%	12	$0.00
99306	Prolong nursin fac eval 15m	0%	12	$0.00
A4617	Mouth piece	0%	21	$0.00
94070		0%	26	$0.00
G8431	Screening for depression is documented as being positive and a follow-up plan is documented	0%	12	$0.00
90685		0%	29	$0.00
Q0244	Injection, casirivimab and imdevimab, 1200 mg	0%	14	$0.00
99473		0%	30	$0.00
75580		0%	14	$0.00
95957		0%	12	$0.00
G8938	Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible	0%	13	$0.00
0690T		0%	94	$0.00
78725		0%	14	$0.00
G9920	Screening performed and negative	0%	12	$0.00
90681		0%	12	$0.00
91307		0%	295	$0.00
G8950	Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented	0%	1,090	$0.00
G9903	Patient screened for tobacco use and identified as a tobacco non-user	0%	3,129	$0.00
99058		0%	667	$0.00
G8420	Bmi is documented within normal parameters and no follow-up plan is required	0%	6,880	$0.00
G8418	Bmi is documented below normal parameters and a follow-up plan is documented	0%	2,271	$0.00
91301		0%	114	$0.00
G8754	Most recent diastolic blood pressure < 90 mmhg	0%	1,542	$0.00
88738		0%	252	$0.00
90680		0%	922	$0.00
36416		0%	1,616	$0.00
90677		0%	253	$0.00
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	0%	83	$0.00
80329		0%	37	$0.00
80050	General health panel	0%	417	$0.00
0346T		0%	144	$0.00
90697		0%	42	$0.00
90619		0%	365	$0.00
G9275	Documentation that patient is a current non-tobacco user	0%	762	$0.00
G8419	Bmi documented outside normal parameters, no follow-up plan documented, no reason given	0%	94	$0.00
G8883	Biopsy results reviewed, communicated, tracked and documented	0%	125	$0.00
90647		0%	658	$0.00
90698		0%	545	$0.00
99070		0%	17	$0.00
99172		0%	227	$0.00
G8430	Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an acute health crisis where time is of the essence and delay of treatment would jeopardize the patient's health status)	0%	210	$0.00
S0020	Injection, bupivicaine hydrochloride, 30 ml	0%	128	$0.00
83014		0%	182	$0.00
A4556	Electrodes, (e.g., apnea monitor), per pair	0%	379	$0.00
99474		0%	47	$0.00
90660		0%	13	$0.00
90620		0%	26	$0.00
90381		0%	13	$0.00
84432		0%	63	$0.00
90723		0%	49	$0.00
99458		0%	12	$0.00
G8981	Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals	0%	17	$0.00
S9451	Exercise classes, non-physician provider, per session	0%	27	$0.00
G8982	Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	18	$0.00
1036F		0%	26	$0.00
G9637	Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)	0%	44	$0.00
97550		0%	47	$0.00
97750		0%	16	$0.00
87632		0%	37	$0.00
91306		0%	16	$0.00
91303		0%	28	$0.00
J3490	Unclassified drugs	0%	19	$0.00
3074F		0%	27	$0.00
G8711	Prescribed antibiotic on or within 3 days after the episode date	0%	14	$0.00
90696		0%	12	$0.00
3008F		0%	21	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGARCIA, ANDRES (TREASURER)